GEN Exclusives

More »

GEN News Highlights

Back to Item »

Stallergenes and CMC Biopharmaceuticals Collaborate to Advance Allergy Drug

Manufacturing agreement for recombinant Bet v 1 will help take Stallergene’s Oralair into Phase III trials.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

More »